
Sona Nanotech Enters into a Manufacturing Service Agreement and a Sale Letter of Intent Agreement for 2mm Tests
March 30, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTC Pink: SNANF) (the “Company”) entered into service...
March 30, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTC Pink: SNANF) (the “Company”) entered into service...
SONA NANOTECH OBTAINS NEW OTC TRADING SYMBOL March 20, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA, OTC...
Halifax, Nova Scotia, March 19, 2020 – Sona Nanotech Inc. (“Sona”) (CSE: SONA) (OTC: LMTCF) is pleased to provide an...
March 17, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA) (the “Company”) is pleased to announce that it...
Halifax, Nova Scotia, March 12, 2020 – Sona Nanotech Inc. (“Sona”) (CSE: SONA) (OTC: LMTCF) is pleased to provide a...
Halifax, Nova Scotia, March. 6, 2020 – Sona Nanotech Inc. (“Sona”) (CSE: SONA)(OTC:LMTCF) is pleased to provide an update on...
Halifax, Nova Scotia, March 3, 2020 – Sona Nanotech Inc. (“Sona”) (CSE: SONA) and GE Healthcare Life Sciences will jointly...
Halifax, Nova Scotia, February 18, 2020 – Sona Nanotech Inc. (CSE: SONA) has announced a partnership with UK-based medical technology...
Halifax, Nova Scotia, Feb. 13, 2020 – Sona Nanotech Inc. (“Sona”) (CSE: SONA) has secured an agreement with The Native...
HALIFAX, Feb 10, 2020 — Sona Nanotech Inc. (“Sona”) (CSE: SONA) is deploying its proprietary nanotechnology in the development...
Press release Tests prove Sona’s gold nanorods “perfectly suited” for competitive lateral flow assays Sona Nanotech’s unique gold nanorods are...
Diagnostics companies sign new commercial agreement to address limitations in development of multiplex point-of-care lateral flow assay diagnostic tests Halifax,...
© 2021 Sona Nanotech. All rights reserved. Privacy Policy